Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 53 Neoplasms 36 Lung Neoplasms 25 Colorectal Neoplasms 23 Prostatic Neoplasms 17 Uterine Cervical Neoplasms 14 Motor Activity 13 Colonic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Rectal Neoplasms 9 Anxiety Disorders 9 Urinary Bladder Neoplasms 8 Pancreatic Neoplasms 8 Obesity 8 Melanoma 8 Depression 8 Lymphoma 7 Hematologic Neoplasms 7 Endometrial Neoplasms 7 Vulvar Neoplasms 6 Ovarian Neoplasms 6 Head and Neck Neoplasms 6 Breast Carcinoma In Situ 6 Sarcoma 5 Pain 5 Hematopoietic and Lymphatic System Neoplasm 5 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Papillomavirus Infections 4 Neoplasm Metastasis 4

Interventions

Ipilimumab 17 Nivolumab 15 incomplete Freund's adjuvant 8 Cyclophosphamide 7 CTLA-4 Antigen 7 pembrolizumab 6 Ranibizumab 6 sargramostim 5 Radiosurgery 5 Blood Specimen Collection 5 tebentafusp 4 Temozolomide 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 MART-1 Antigen 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Biopsy 4 Bevacizumab 4 fludarabine phosphate 3 fludarabine 3 aflibercept 3 Thalidomide 3 Sunitinib 3 Specimen Handling 3 MAGEA3 protein, human 3 Interleukin-2 3 130-nm albumin-bound paclitaxel 3 relatlimab 2 olaparib 2 montanide ISA 51 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uveal Melanoma × Methods × Clear all

NCT06075589 2026-03-19

Psychoeducation for Uveal Melanoma

Jonsson Comprehensive Cancer Center

Phase NA Active not recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡